Avalyn Pharma Inc. Common Stock

AVLN | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.63

-$0.08 (-0.31%)

At close: Oct 30, 2026, 4:00 PM ET

$23.20

-$2.43 (-9.48%)

Pre-market: Nov 2, 2026, 7:45 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.14B

Enterprise Value $800.94M

Beta -1.13

Average Volume 314.97K

Shares Outstanding (Diluted) 44.33M

Shares Change YoY N/A

Institutional Ownership N/A

Exchange NASDAQ

ISIN US05348Y1055

Price Performance

Price Change 1M -10.0%

Price Change 3M -11.0%

Price Change 6M -14.1%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -18.7%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -24.4%

Valuation

PE Ratio -19.87

Forward PE N/A

PEG Ratio -0.20

Forward PEG 0.71

PS Ratio N/A

Forward PS N/A

PB Ratio 2.85

P/FCF Ratio -20.09

P/Adj. FCF Ratio -19.68

P/OCF Ratio -20.34

EV/Sales N/A

EV/EBIT -13.79

EV/EBITDA -13.84

EV/FCF -14.16

Earnings Yield -5.0%

FCF Yield -5.0%

Adj. FCF Yield -5.1%

Financial Health

Net Cash $336.81M

Total Debt $17.11M

Cash & Short-Term Investments $352.43M

Total Assets $425.45M

Current Ratio 33.10

Quick Ratio 33.10

Debt / Equity Ratio 0.04

Debt / EBITDA -0.30

Debt / FCF -0.30

OCF / Debt -3.27

Interest Coverage -160.00

Altman Z-Score 24.63

Piotroski F-Score 0

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -2.1%

Returns

Return on Assets -13.1%

Return on Equity -83.2%

Return on Invested Capital -14.3%

Return on Capital Employed -14.3%

Return on Tangible Assets -13.1%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y -56.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.71

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $60.00

Price Target Upside 134.1%

Cash Flow

Operating Cash Flow $-55.97M

Free Cash Flow $-56.55M

Adj. Free Cash Flow $-57.75M

FCF Per Share -$1.28

OCF Per Share -$1.26

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-110K

Operating Income $-59.2M

EBITDA $-57.89M

Net Income $-55.8M

EPS (Diluted) -$1.29

Revenue / Employee N/A

Profit / Employee $-1.01M

Employees 55